CollPlant Biotechnologies (CLGN) Assets (2018 - 2025)

CollPlant Biotechnologies' Assets history spans 8 years, with the latest figure at $10.8 million for Q4 2025.

  • For Q4 2025, Assets fell 42.36% year-over-year to $10.8 million; the TTM value through Dec 2025 reached $10.8 million, down 42.36%, while the annual FY2025 figure was $10.8 million, 42.36% down from the prior year.
  • Assets reached $10.8 million in Q4 2025 per CLGN's latest filing, down from $18.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $51.2 million in Q4 2021 to a low of $10.8 million in Q4 2025.
  • Average Assets over 5 years is $30.5 million, with a median of $34.1 million recorded in 2023.
  • Peak YoY movement for Assets: soared 372.5% in 2021, then crashed 45.17% in 2024.
  • A 5-year view of Assets shows it stood at $51.2 million in 2021, then decreased by 26.27% to $37.8 million in 2022, then decreased by 9.64% to $34.1 million in 2023, then plummeted by 45.17% to $18.7 million in 2024, then crashed by 42.36% to $10.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Assets are $10.8 million (Q4 2025), $18.7 million (Q4 2024), and $34.1 million (Q4 2023).